Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms-Reference-Cited by-同舟云学术

Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms

Published:2019-06 Issue:6 Volume:44 Page:452-458
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Long Tingting,Yang Nengan,Zhou Ming,Chen Dengming,Li Yulai,Li Jian,Tang Yongxiang,Liu Zhaoqian,Li Zibo,Hu Shuo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;JAMA Oncol,2017

2. Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA–conjugated somatostatin receptor targeting peptides and (18)F-DOPA;Eur J Nucl Med Mol Imaging,2017

3. Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake;J Nucl Med,1999

4. Prospective study of 68Ga-DOTATATE positron emission tomography/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites;J Clin Oncol,2016

5. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors;J Nucl Med,2018

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT;EJNMMI Physics;2024-08-29

3. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

4. A Rare Case of Follicular Dendritic Cell Tumor of the Abdominal Cavity Visualized by 18F-AlF-NOTA-Octreotide PET/CT;Clinical Nuclear Medicine;2024-07-03

5. Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms;Expert Review of Endocrinology & Metabolism;2024-06-05